Ib-iiib Non-small Cell Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-05-21
Clinical Trial Update: Monitoring the Efficacy of Duvalizumab Combined With Neoadjuvant Chemotherapy for Ib-IIIb NSCLC by Sequencing of Immune Receptor Repertoire: a Prospective, One Arm Clinical Study [Phase 2]
Phase 2 trial investigating duvalizumab with neoadjuvant chemotherapy for Ib-IIIb non-small cell lung cancer; current status unknown.